{"id":"W4387374139","doi":"10.1016/j.diabres.2023.110908","title":"Rationale and design of a randomised phase III registration trial investigating finerenone in participants with type 1 diabetes and chronic kidney disease: The FINE-ONE trial","year":2023,"lang":"en","type":"article","venue":"Diabetes Research and Clinical Practice","topic":"Hormonal Regulation and Hypertension","field":"Medicine","cited_by":57,"is_retracted":false,"has_abstract":true,"ca_institutions":"Toronto General Hospital; University of Toronto; University Health Network","funders":"Regeneron Pharmaceuticals; CSL Behring; Gilead Sciences; Novo Nordisk; Sanofi; Bayer; AstraZeneca; Eli Lilly and Company; Bristol-Myers Squibb","keywords":"Medicine; Diabetes mellitus; Type 2 diabetes; Kidney disease; Randomized controlled trial; Clinical trial; Disease; MEDLINE; Internal medicine; Physical therapy; Endocrinology","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.006928425,0.00009601594,0.0003784739,0.0001039432,0.0001529997,0.0000592953,0.00004449528,0.00007683196,0.00002436777],"category_scores_gemma":[0.05909536,0.00006112664,0.00002643966,0.0004768528,0.0005894675,0.000204359,0.00005186773,0.000391455,0.00000283835],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00001689733,"about_ca_system_score_gemma":0.0007230724,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00001182311,"about_ca_topic_score_gemma":0.00001226483,"domain_scores_codex":[0.9972971,0.0009782753,0.0005742753,0.0002837553,0.0005647485,0.0003018093],"domain_scores_gemma":[0.986255,0.01257059,0.0001824536,0.0001853448,0.0003618553,0.0004447002],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.954731,0.001462122,0.005298411,0.0002101072,0.0002908263,0.00003043605,0.0002382491,0.00001848887,0.01183534,0.0003089341,0.002567253,0.02300878],"study_design_scores_gemma":[0.891683,0.01412035,0.01842087,0.0004290704,0.0003493268,0.000001379644,0.0002177315,0.07129147,0.0004164751,0.0009641135,0.001958946,0.0001472103],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9856855,0.001174222,0.00001306821,0.01056072,0.00003412661,0.002451201,0.000006770423,0.00001372192,0.0000607328],"genre_scores_gemma":[0.997539,0.001245271,0.0002604441,0.0002641083,0.000262298,0.0001548798,0.00007286062,0.00001156357,0.0001895713],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.07127298,"threshold_uncertainty_score":0.9488303,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.3141812149177413,"score_gpt":0.4790312131552177,"score_spread":0.1648499982374764,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}